151 related articles for article (PubMed ID: 38032636)
41. Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients.
Dong Z; Kong L; Wan Z; Zhu F; Zhong M; Lv Y; Zhao P; Shi H
Sci Rep; 2019 Nov; 9(1):16894. PubMed ID: 31729406
[TBL] [Abstract][Full Text] [Related]
42. Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers.
Imamura Y; Morikawa T; Liao X; Lochhead P; Kuchiba A; Yamauchi M; Qian ZR; Nishihara R; Meyerhardt JA; Haigis KM; Fuchs CS; Ogino S
Clin Cancer Res; 2012 Sep; 18(17):4753-63. PubMed ID: 22753589
[TBL] [Abstract][Full Text] [Related]
43. External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS.
Alwers E; Bläker H; Walter V; Jansen L; Kloor M; Arnold A; Sieber-Frank J; Herpel E; Tagscherer KE; Roth W; Chang-Claude J; Brenner H; Hoffmeister M
BMC Cancer; 2019 Jul; 19(1):681. PubMed ID: 31296182
[TBL] [Abstract][Full Text] [Related]
44. G12V and G12C mutations in the gene KRAS are associated with a poorer prognosis in primary colorectal cancer.
Hayama T; Hashiguchi Y; Okamoto K; Okada Y; Ono K; Shimada R; Ozawa T; Toyoda T; Tsuchiya T; Iinuma H; Nozawa K; Matsuda K
Int J Colorectal Dis; 2019 Aug; 34(8):1491-1496. PubMed ID: 31309326
[TBL] [Abstract][Full Text] [Related]
45. Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer.
Eilertsen IA; Sveen A; Strømme JM; Skotheim RI; Nesbakken A; Lothe RA
Int J Cancer; 2019 Feb; 144(4):841-847. PubMed ID: 30121958
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer.
Kadowaki S; Kakuta M; Takahashi S; Takahashi A; Arai Y; Nishimura Y; Yatsuoka T; Ooki A; Yamaguchi K; Matsuo K; Muro K; Akagi K
World J Gastroenterol; 2015 Jan; 21(4):1275-83. PubMed ID: 25632202
[TBL] [Abstract][Full Text] [Related]
47. Correlation between RAS Test Results and Prognosis of Metastatic Colorectal Cancer Patients: a Report from Western Iran.
Payandeh M; Shazad B; Sadeghi M; Shahbazi M
Asian Pac J Cancer Prev; 2016; 17(4):1729-32. PubMed ID: 27221845
[TBL] [Abstract][Full Text] [Related]
48. Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis.
Chen FW; Sundaram V; Chew TA; Ladabaum U
Clin Gastroenterol Hepatol; 2017 May; 15(5):728-737.e3. PubMed ID: 27856366
[TBL] [Abstract][Full Text] [Related]
49. Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer.
Kang M; Shen XJ; Kim S; Araujo-Perez F; Galanko JA; Martin CF; Sandler RS; Keku TO
Cancer Biomark; 2013; 13(5):359-66. PubMed ID: 24440976
[TBL] [Abstract][Full Text] [Related]
50. KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers.
Phipps AI; Buchanan DD; Makar KW; Win AK; Baron JA; Lindor NM; Potter JD; Newcomb PA
Br J Cancer; 2013 Apr; 108(8):1757-64. PubMed ID: 23511557
[TBL] [Abstract][Full Text] [Related]
51. Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status.
Myte R; Gylling B; Häggström J; Häggström C; Zingmark C; Löfgren Burström A; Palmqvist R; Van Guelpen B
Int J Cancer; 2019 Jul; 145(2):327-337. PubMed ID: 30613980
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathological Features and Prognostic Value of KRAS/NRAS/BRAF Mutations in Colorectal Cancer Patients of Central China.
Chang XN; Shang FM; Jiang HY; Chen C; Zhao ZY; Deng SH; Fan J; Dong XC; Yang M; Li Y; Cai KL; Liu L; Liu HL; Nie X
Curr Med Sci; 2021 Feb; 41(1):118-126. PubMed ID: 33582915
[TBL] [Abstract][Full Text] [Related]
53. Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and rectum defines two molecular entities.
Silva P; Albuquerque C; Lage P; Fontes V; Fonseca R; Vitoriano I; Filipe B; Rodrigues P; Moita S; Ferreira S; Sousa R; Claro I; Nobre Leitão C; Chaves P; Dias Pereira A
Int J Mol Med; 2016 Sep; 38(3):687-702. PubMed ID: 27430658
[TBL] [Abstract][Full Text] [Related]
54. Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.
De Roock W; Jonker DJ; Di Nicolantonio F; Sartore-Bianchi A; Tu D; Siena S; Lamba S; Arena S; Frattini M; Piessevaux H; Van Cutsem E; O'Callaghan CJ; Khambata-Ford S; Zalcberg JR; Simes J; Karapetis CS; Bardelli A; Tejpar S
JAMA; 2010 Oct; 304(16):1812-20. PubMed ID: 20978259
[TBL] [Abstract][Full Text] [Related]
55. Young-age onset colorectal cancer in Brazil: Analysis of incidence, clinical features, and outcomes in a tertiary cancer center.
Silva ACB; Vicentini MFB; Mendoza EZ; Fujiki FK; da Fonseca LG; Braghiroli MIFM; Hoff PM
Curr Probl Cancer; 2019 Oct; 43(5):477-486. PubMed ID: 30826126
[TBL] [Abstract][Full Text] [Related]
56. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.
Imamura Y; Lochhead P; Yamauchi M; Kuchiba A; Qian ZR; Liao X; Nishihara R; Jung S; Wu K; Nosho K; Wang YE; Peng S; Bass AJ; Haigis KM; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Mol Cancer; 2014 May; 13():135. PubMed ID: 24885062
[TBL] [Abstract][Full Text] [Related]
57. Associations of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment.
Carr PR; Jansen L; Walter V; Kloor M; Roth W; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
Am J Clin Nutr; 2016 Jan; 103(1):192-200. PubMed ID: 26607936
[TBL] [Abstract][Full Text] [Related]
58. Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer.
Pichler M; Winter E; Stotz M; Eberhard K; Samonigg H; Lax S; Hoefler G
Br J Cancer; 2012 May; 106(11):1826-32. PubMed ID: 22549179
[TBL] [Abstract][Full Text] [Related]
59. Association of Simultaneous vs Delayed Resection of Liver Metastasis With Complications and Survival Among Adults With Colorectal Cancer.
Wu Y; Mao A; Wang H; Fang G; Zhou J; He X; Cai S; Wang L
JAMA Netw Open; 2022 Sep; 5(9):e2231956. PubMed ID: 36121654
[TBL] [Abstract][Full Text] [Related]
60. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
